Absence of mutations in the growth hormone (GH)‐releasing hormone receptor gene in GH‐secreting pituitary adenomas
暂无分享,去创建一个
B. Harding | R. Thakker | M. Levine | R. Salvatori | Xiaoguang Fan | J. Eswara | M. Lopes | David Ellison | P. Lees | I. Yang
[1] M. Buchfelder,et al. A polymorphism in the growth hormone (GH)-releasing hormone (GHRH) receptor gene is associated with elevated response to GHRH by human pituitary somatotrophinomas in vitro. , 2000, Biochemical and biophysical research communications.
[2] D. Lüdecke,et al. Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas , 2000, Clinical endocrinology.
[3] M. Nakazato,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.
[4] D. Doyle,et al. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. , 1999, The New England journal of medicine.
[5] K. Miller,et al. Denaturing gradient gel electrophoresis (DGGE): a rapid and sensitive technique to screen nucleotide sequence variation in populations. , 1999, BioTechniques.
[6] B. Gaylinn. Molecular and cell biology ofthe growth hormone-releasing hormone receptor , 1999 .
[7] F. Gracia‐Navarro,et al. Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations. , 1999, Endocrinology.
[8] M. Levine,et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. , 1999, The Journal of clinical endocrinology and metabolism.
[9] L. Brooks,et al. A DNA polymorphism discovery resource for research on human genetic variation. , 1998, Genome research.
[10] S. Asa,et al. The cytogenesis and pathogenesis of pituitary adenomas. , 1998, Endocrine reviews.
[11] A. Lania,et al. G protein abnormalities in pituitary adenomas , 1998, Molecular and Cellular Endocrinology.
[12] K. Mayo,et al. Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. , 1998, Molecular endocrinology.
[13] S. Amselem,et al. Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. , 1998, The Journal of clinical endocrinology and metabolism.
[14] H. Schulte,et al. Structure and regulation of the human growth hormone-releasing hormone receptor gene. , 1998, Molecular endocrinology.
[15] H. Maheshwari,et al. The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[16] Roy G. Smith,et al. Peptidomimetic regulation of growth hormone secretion. , 1997, Endocrine reviews.
[17] P. Rocmans,et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. , 1997, The Journal of clinical endocrinology and metabolism.
[18] M. Stoler,et al. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. , 1997, The American journal of pathology.
[19] R. Scully,et al. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. , 1997, The Journal of clinical endocrinology and metabolism.
[20] P. Godfrey,et al. The Growth‐Hormone‐Releasing Hormone Receptor: Signal Transduction, Gene Expression, and Physiological Function in Growth Regulation a , 1996, Annals of the New York Academy of Sciences.
[21] T. Ohnishi,et al. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.
[22] P. Chanson,et al. The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. , 1995, Molecular endocrinology.
[23] S. Swillens,et al. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. , 1995, Molecular endocrinology.
[24] K. Chihara,et al. Human TRH receptor messenger ribonucleic acid levels in normal and adenomatous pituitary: analysis by the competitive reverse transcription polymerase chain reaction method , 1995, Clinical endocrinology.
[25] H. Watanobe,et al. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly , 1995, Neuropeptides.
[26] A. Colao,et al. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. , 1994, European journal of endocrinology.
[27] H. Watanobe,et al. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly , 1993, Neuropeptides.
[28] T. Satoh,et al. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene. , 1993, Biochemical and biophysical research communications.
[29] Aldons J. Lusis,et al. Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.
[30] C. Francomano,et al. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Sawchenko,et al. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant , 1991, Nature.
[32] F. Bloom,et al. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene , 1991, Nature.
[33] K. Kovacs,et al. Clonal origin of pituitary adenomas. , 1990, The Journal of clinical endocrinology and metabolism.
[34] S. Asa,et al. Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[35] T. Sano,et al. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.
[36] G. Giannattasio,et al. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.
[37] K. Kovacs,et al. Pathology of growth hormone-producing tumors of the human pituitary. , 1986, Seminars in diagnostic pathology.
[38] B. Scheithauer,et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. , 1984, The Journal of clinical endocrinology and metabolism.
[39] A. Spiegel,et al. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells. , 1983, The Journal of clinical investigation.
[40] N. Ling,et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. , 1982, Science.
[41] J. Bertherat. Nuclear effects of the cAMP pathway activation in somatotrophs. , 1997, Hormone research.
[42] S. Chua,et al. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.
[43] Riccardo Fodde,et al. Mutation detection by denaturing gradient gel electrophoresis (DGGE) , 1994, Human mutation.
[44] M. Thorner,et al. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. , 1993, Molecular endocrinology.
[45] V. Sheffield,et al. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[46] Thomas A. Kunkel,et al. Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[47] N. Ling,et al. Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients. , 1984, The Journal of clinical endocrinology and metabolism.
[48] N. Ling,et al. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. , 1984, The Journal of clinical endocrinology and metabolism.